article thumbnail

The EU AI Act: will regulation drive life science innovation away from Europe?

European Pharmaceutical Review

When the General Data Protection Regulation (GDPR) 1 came into effect in 2018, this appeared to accelerate the migration out of Europe for pharmaceutical clinical trials. About the authors Mike King is Senior Director, Product & Strategy (Quality, Regulatory, Safety & Detect), Digital Products & Solutions at IQVIA.

Medical 105
article thumbnail

Everything You Need to Know About Prior Authorizations in Healthcare

Referral MD

Patient Safety Prior authorization protects patients by: Verifying that prescribed medications or treatments are safe. According to a 2018 AMA survey, 26% of healthcare providers reported waiting three days or more for a decision, highlighting the need for improvements in efficiency. Identify more cost-effective alternatives.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

Data were mainly accessible for smaller firms, products in some therapeutic regions, orphan drugs, first-in-class drugs, therapeutic agents that received accelerated approval, and products between 2014 and 2018. The most telling data on a disconnect between drug prices and research costs has received almost no public attention.

Pharma 255
article thumbnail

Developing the EU’s first intestinal microbiota-based biologic

European Pharmaceutical Review

Since 2018, biotech company Mikrobiomik has been researching, development and producing innovative biological medicines based on the human microbiome. Donor of stools for MBK-01 were screened for pathogens and viruses to ensure safety. Safety and quality of life of the patients participating in the study were also assessed.

Safety 111
article thumbnail

Aurobindo Pharma-Walk-In Interviews for QC/ QA/ Production Departments On 17th Sept’ 2022

Pharma Pathway

Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations. As part of Covid-19 safety measures, candidates are requested to sanitize their hands at the entrance, Maintain social distance and ware face mask before entering the venue. Job Description.

Pharma 88
article thumbnail

Current and future players in the lupus market

Pharmaceutical Technology

The management of SLE and LN consists largely of treatment options that are based on highly efficacious steroids or immune-suppressive therapy with an undesirable safety profile, which includes accrued organ damage, infections and cancer. in 2018 across the 7MM despite being an off-label therapy for lupus.

Marketing 111
article thumbnail

UK medical cannabis manufacturer granted GMP registration

European Pharmaceutical Review

The first good manufacturing practice (GMP) registration of a UK pharmaceutical facility for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API) has been granted since the legalisation of medical cannabis in 2018. The firm’s medicinal cannabis product will be supplied in oil form as an API.